Infectious Disease Diagnostics Market Size, Trends, Growth Drivers and Future Outlook
[Research Report] The infectious disease diagnostics market is expected to grow from US$ 38,366.38 million in 2022 to US$ 59,954.22 million by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030.
Market Insights and Analyst View:
The infectious disease diagnostics market size is expanding with the rising cases of infectious diseases and increasing product launches and product approvals due to development of technologically advanced products. In May 2022, BD launched its fully automated, high-throughput infectious disease molecular diagnostic platform—BD COR MX instrument—in the US. This instrument automates and integrates the complete molecular laboratory workflow, from the processing of samples to the result of the diagnostic test for large, high-throughput labs. The BD COR System eliminates the task of sorting specimens, aiding the lab tech to have minimal interaction with the specimen, thereby freeing up time for other critical lab processes. In response to the growing cases of infectious diseases and the shortage of laboratory capabilities and molecular testing reagents, some diagnostic testing manufacturers offer rapid and easy-to-use devices to facilitate out-of-laboratory testing.
Growth Drivers and Challenges:
Veterinary infectious diseases negatively impact the health of domestic animals, livestock, and wildlife. As a result of intensive animal farming, there are conditions for the emergence and amplification of disease epidemics due to the genetic and physical proximity of the billions of animals, often in frail health, that are raised indoors every year. Moreover, animal farming contributes to the spread of infections from wild animals due to deforestation caused by the expansion of agricultural land use.
Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential to reduce economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally to detect animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infectious Disease Diagnostics Market: Strategic Insights
Market Size Value in US$ 38,366.38 million in 2022 Market Size Value by US$ 59,954.22 million by 2030 Growth rate CAGR of 5.7% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infectious Disease Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 38,366.38 million in 2022 |
| Market Size Value by | US$ 59,954.22 million by 2030 |
| Growth rate | CAGR of 5.7% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Even though conventional virological methods are incredibly reliable, they are time-consuming and labor-intensive procedures. Lateral flow and enzyme-linked immunosorbent assay can be used for rapid detection. Multiplex bead immuno or Luminex assay is a fluorescent beads-based high-throughput quantitative technique used for the detection of multiple antibodies specific for different infectious diseases at the same time in a single reaction, leading to more rapid, economical, and accurate results compared with conventional ELISA. In addition, the protein chip based on surface plasmon resonance (SPR) appears to be a rapid valuable tool in the sero-diagnosis of infection or antibody titration. Recombinant antibodies can also be produced in heterologous systems by using rDNA technology and used for developing diagnostic tests.
Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10–35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK supply lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes. Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR.
Thus, diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals is fueling the diagnostics in veterinary diagnosis.
Low reimbursement rates for most diagnostic tests discourage manufacturing companies from developing new tests and conducting research on a large scale to support widespread use. Also, reimbursement remains low if there is data with no expected results to support the cost-effectiveness of the new test or prove the existing test.
Difficulties and concerns about the reimbursement of new or expensive diagnostic tests can impede innovation and pose significant challenges to the widespread deployment of diagnostic technologies. In the US, reimbursement comprises coverage by third-party payers, coding of health services or conditions to determine payment, and determination of payment level.
For outpatient tests with Current Procedural Terminology (CPT) codes, the Medicare Coverage Advisory Committee promotes the Centers for Medicare & Medicaid Services (CMS) regarding diagnostic test coverage, including the determination of sufficient evidence and health benefits. However, most Medicare reimbursement decisions are made locally and not at the national level. Coverage for diagnostic tests differs as per region. Also, the lack of standards in determining coverage can pose challenges for the development and availability of a new diagnostic product.
In some cases, the reimbursement does not cover test cost, which limits laboratories in offering the test and reduces test availability and use. In other cases, the charge may be high but may leave a considerable cost to the patient, which limits physicians from ordering the test routinely. Compliance and billing remain challenges for clinical laboratories and limit testing availability. Thus, the inadequate reimbursement scenario hinders the growth of the infectious disease diagnostics market.
Report Segmentation and Scope:
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Segmental Analysis:
The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030. The kits and reagents segment is growing due to the presence of a large number of manufacturers such as Abbott; F. Hoffmann-La Roche Ltd; and Bio-Rad Laboratories, Inc. Further, in response to the growing cases of infectious diseases such as HAIs, influenza, and HIV and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. Moreover, kits and reagents are frequently used in various research processes, and there is a constant rise in product launches. For instance, in July 2021, Cepheid announced that it had received CE-IVD clearance for Xpert HIV-1 Viral Load XC and Xpert HIV-1 Qual XC, next-generation extended-coverage (XC) tests for HIV testing. Xpert HIV-1 Viral Load XC provides a second target for HIV-1 detection that provides extended strain coverage to improve performance and reduce the risk of false negative results due to gene mutations or deletions. Hence, owing to the presence of the various market players that are offering multiple reagents & kits and the rise in technological advancements, the segment is expected to grow during the forecast period.
The software and service segment is anticipated to grow in the coming years owing to factors such as rising technological advancement and the adoption of new software to reduce the infectious disease burden. Many companies are launching software to analyze the rising incidence of infectious diseases, predict trends over time and breakout situations, and assess the effectiveness of containment measures. Consequently, several statistical models have been established, primarily based on the susceptible-exposed-infected-recovered or removed (SEIR) model. Additionally, inspired by multidisciplinary and collaborative efforts in the scientific community, the Institute for Disease Modeling has been building modeling tools that result from extensive collaboration among members of research and software teams. These tools provide quantitative and analytical means to represent the transmission of infectious diseases with a model. IDM software tools are freely and openly shared with the scientific community to speed up disease eradication efforts with the help of computational modeling. Thus, such initiatives taken by the key players are also expected to boost the segment growth in the coming years.
Regional Analysis:
Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players. Aging is a prominent risk factor for infectious diseases, as people above 60 generally have compromised immunity. According to a study published by the Population Reference Bureau in 2020, the population of individuals aged 65 and above was 55 million in the US in 2020, and the number is expected to reach 95 million by 2060. Regulatory agencies in the US are imposing favorable policies for the development of point-of-care (POC) products for the diagnosis and treatment of various indications. In March 2021, the US Food Drug Administration (FDA) authorized Binx Health IO CT/NG Assay for community-based clinics, urgent care settings, and outpatient healthcare facilities; it is the first POC testing product for diagnosing chlamydial and gonorrheal infections. In May 2022, Becton Dickinson and Company (BD), one of the leading global medical technology companies, announced the launch of its new, fully automated, high-throughput molecular diagnostics platform for infectious diseases for the market in the US. The new BD COR MX instrument was launched as an analytical instrument option for the BD COR platform, with 510(k) clearance from the FDA. The BD CTGCTV2 molecular assay, the first test available on the new system, is a single test that detects the three most prevalent non-viral sexually transmitted infections (STIs)—Neisseria gonorrhoeae (GC), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV).
Infectious Disease Diagnostics Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives by key players operating in the Infectious Disease Diagnostics Market are listed below:
- In January 2023, Trinity Biotech announced a strategic partnership with imaware Inc that combined their built-to-partner digital health platform with Trinity Biotech’s advanced reference laboratory facilities to power the Digital Health Industry with at-home and remote testing programs.
- In November 2022, Bio-Rad Laboratories Inc expanded its product portfolio of independent quality controls, including InteliQ and Liquichek compact vials. The products will be used for Abbott's Alinity CI-Series, which is integrated with clinical chemistry and immunoassay testing instruments.
- In December 2021, F. Hoffmann-La Roche Ltd launched the first infectious disease tests on the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. These include cobas HIV-1, cobas HBV, cobas HCV, cobas HIV-1/HIV-2 Qualitative, and the cobas omni Utility Channel kit. These launches expand the Roche Molecular portfolio offering by providing standardized performance and efficiencies across low, medium, and high-volume molecular laboratory testing needs.
Competitive Landscape and Key Companies:
Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Technology, Application Type, Testing Type, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving and restraining factors that will affect the infectious disease diagnostics market in the coming years Growth of the global infectious disease diagnostic market is majorly driven by increase in prevalence of infectious disease such as hepatitis, influenza, COVID-19, & human immuno deficiency virus (HIV); rise in demand for point-of-care diagnostic test; increase in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, lack of reimbursement policy is likely to hinder the market growth.
Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the methods utilized by hospitals, clinical laboratories, and others to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in the identification of the kind of pathogen. Also, the level of the degree to which the disease is spread in the body. The diagnostic procedure may be sent with the aid of conventional diagnostic tests or point-of-care testing tools.
The infectious disease diagnostics market majorly consists of the players such as F.Hoffmann-La Roche, Ltd.; Danaher Corporation; BD; bioMérieux SA; AccuBioTech Co., Ltd.; Bio-Rad Laboratories, Inc.; ACON Laboratories, Inc.; Abbott; Trinity Biotech; and Cardinal Health, Inc. amongst others.
The infectious disease diagnostics market, by disease indication, is bifurcated into human testing and veterinary testing. In 2022, the human segment held a larger share of the market, by testing type. However, the veterinary segment is expected to witness a higher growth during the forecast period.
1. Introduction 39
1.1 The Insight Partners Research Report Guidance. 39
1.2 Market Segmentation. 40
2. Executive Summary 42
2.1 Key Insights. 42
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43
3. Research Methodology 44
3.1 Coverage. 45
3.2 Secondary Research. 45
3.3 Primary Research. 45
4. Infectious Disease Diagnostics Market Landscape 47
4.1 Overview. 47
4.2 PEST Analysis. 47
4.2.1 Global PEST Analysis. 47
5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48
5.1 Market Drivers: 48
5.1.1 Rising Incidence of Infectious Diseases. 48
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50
5.2 Market Restraints. 50
5.2.1 Inadequate Reimbursement Scenario. 50
5.3 Market Opportunities. 51
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51
5.4 Future Trends. 52
5.4.1 Rising Number of Product Approvals and Launches. 52
5.5 Impact Analysis: 52
6. Infectious Disease Diagnostics Market - Global Market Analysis 54
6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54
7. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Product 56
7.1 Overview. 56
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
7.3 Kits & Reagents. 57
7.3.1 Overview. 57
7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57
7.4 Instruments. 58
7.4.1 Overview. 58
7.4.2 Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58
7.5 Software & Services. 59
7.5.1 Overview. 59
7.5.2 Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59
8. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Technology 60
8.1 Overview. 60
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
8.3 Biosensor-based. 61
8.3.1 Overview. 61
8.3.2 Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61
8.4 Immunodiagnostics. 62
8.4.1 Overview. 62
8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62
8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 63
8.5 Molecular-Based Diagnostic Techniques. 64
8.5.1 Overview. 64
8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64
8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 64
8.6 Clinical Biology. 66
8.6.1 Overview. 66
8.6.2 Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66
8.7 Others. 67
8.7.1 Overview. 67
8.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67
9. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Application Type 68
9.1 Overview. 68
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
9.3 Point-of-Care Testing. 69
9.3.1 Overview. 69
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69
9.4 Laboratory Testing. 70
9.4.1 Overview. 70
9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70
10. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Testing Type 71
10.1 Overview. 71
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
10.3 Human Testing. 72
10.3.1 Overview. 72
10.3.2 Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72
10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 73
10.4 Veterinary Testing. 74
10.4.1 Overview. 74
10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74
11. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by End User 75
11.1 Overview. 75
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
11.3 Diagnostic Laboratories. 76
11.3.1 Overview. 76
11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76
11.4 Hospitals and Clinics. 77
11.4.1 Overview. 77
11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77
11.5 Research Institutes. 78
11.5.1 Overview. 78
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78
11.6 Homecare Settings. 80
11.6.1 Overview. 80
11.6.2 Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80
11.7 Others. 81
11.7.1 Overview. 81
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81
12. Infectious Disease Diagnostics Market - Geographical Analysis 82
12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82
12.1.1 Overview. 82
12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 83
12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 84
12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 84
12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 85
12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 85
12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 86
12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 86
12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 87
12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87
12.1.8.1 US. 88
12.1.8.1.1 Overview.. 88
12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 88
12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 90
12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 90
12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 91
12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 92
12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 92
12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 92
12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 93
12.1.8.2 Canada. 94
12.1.8.2.1 Overview.. 94
12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 95
12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 96
12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 96
12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 97
12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 97
12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 98
12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 98
12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 99
12.1.8.3 Mexico. 100
12.1.8.3.1 Overview.. 100
12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 101
12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 102
12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 102
12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 103
12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 103
12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 103
12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 104
12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 104
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105
12.2.1 Overview. 105
12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 106
12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 107
12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 107
12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 108
12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 108
12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 109
12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 109
12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 110
12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110
12.2.8.1 UK.. 111
12.2.8.1.1 Overview.. 111
12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 111
12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 113
12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 113
12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 114
12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 114
12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 115
12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 115
12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 116
12.2.8.2 Germany. 117
12.2.8.2.1 Overview.. 117
12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 118
12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 119
12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 119
12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 120
12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 120
12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 121
12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 121
12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 122
12.2.8.3 France. 123
12.2.8.3.1 Overview.. 123
12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 123
12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 125
12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 125
12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 126
12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 126
12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 127
12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 127
12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 128
12.2.8.4 Italy. 129
12.2.8.4.1 Overview.. 129
12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 129
12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 131
12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 131
12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 132
12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 132
12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 132
12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 133
12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 133
12.2.8.5 Spain. 134
12.2.8.5.1 Overview.. 134
12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 134
12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 136
12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 136
12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 137
12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 137
12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 137
12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 138
12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 138
12.2.8.6 Rest of Europe. 139
12.2.8.6.1 Overview.. 139
12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 139
12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 141
12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 141
12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 142
12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 142
12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 143
12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 143
12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 144
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145
12.3.1 Overview. 145
12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 146
12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 147
12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 147
12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 148
12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 148
12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 149
12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 149
12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 150
12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151
12.3.8.1 China. 151
12.3.8.1.1 Overview.. 151
12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 153
12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 153
12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 154
12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 154
12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 155
12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 155
12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 156
12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 156
12.3.8.2 Japan. 157
12.3.8.2.1 Overview.. 157
12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 157
12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 159
12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 159
12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 160
12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 160
12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 160
12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 161
12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 161
12.3.8.3 India. 162
12.3.8.3.1 Overview.. 162
12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 162
12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 164
12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 164
12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 165
12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 165
12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 165
12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 166
12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 166
12.3.8.4 South Korea. 167
12.3.8.4.1 Overview.. 167
12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 167
12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 169
12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 169
12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 170
12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 170
12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 170
12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 171
12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 171
12.3.8.5 Australia. 172
12.3.8.5.1 Overview.. 172
12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 172
12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 174
12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 174
12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 175
12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 175
12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 175
12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 176
12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 176
12.3.8.6 Rest of Asia Pacific. 177
12.3.8.6.1 Overview.. 177
12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 177
12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 179
12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 179
12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 180
12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 180
12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 181
12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 181
12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 182
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183
12.4.1 Overview. 183
12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 184
12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 185
12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 185
12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 186
12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 186
12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 187
12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 187
12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 188
12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188
12.4.7.2 Saudi Arabia. 189
12.4.7.2.1 Overview.. 189
12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 189
12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 191
12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 191
12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 192
12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 192
12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 192
12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 193
12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 193
12.4.7.3 South Africa. 194
12.4.7.3.1 Overview.. 194
12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 194
12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 196
12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 196
12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 197
12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 197
12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 197
12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 198
12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 198
12.4.7.4 UAE. 199
12.4.7.4.1 Overview.. 199
12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 199
12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 201
12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 201
12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 202
12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 202
12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 202
12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 203
12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 203
12.4.7.5 Rest of Middle East & Africa. 204
12.4.7.5.1 Overview.. 204
12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 204
12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 206
12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 206
12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 207
12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 207
12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 208
12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 208
12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 209
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210
12.5.1 Overview. 210
12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 211
12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 212
12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 212
12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 213
12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 213
12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 214
12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 214
12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 215
12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215
12.5.8.1 Brazil 216
12.5.8.1.1 Overview.. 216
12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 216
12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 218
12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 218
12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 219
12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 219
12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 219
12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 220
12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 220
12.5.8.2 Argentina. 221
12.5.8.2.1 Overview.. 221
12.5.8.2.2 Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
12.5.8.2.3 Argentina: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 221
12.5.8.2.4 Argentina: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 223
12.5.8.2.4.1 Argentina: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 223
12.5.8.2.4.2 Argentina: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 224
12.5.8.2.5 Argentina: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 224
12.5.8.2.6 Argentina: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 224
12.5.8.2.6.1 Argentina: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 225
12.5.8.2.7 Argentina: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 225
12.5.8.3 Rest of South & Central America. 226
12.5.8.3.1 Overview.. 226
12.5.8.3.2 Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
12.5.8.3.3 Rest of South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 226
12.5.8.3.4 Rest of South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 227
12.5.8.3.4.1 Rest of South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 227
12.5.8.3.4.2 Rest of South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 228
12.5.8.3.5 Rest of South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 228
12.5.8.3.6 Rest of South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 229
12.5.8.3.6.1 Rest of South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 229
12.5.8.3.7 Rest of South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 230
13. Industry Landscape 231
13.1 Overview. 231
13.2 Growth Strategies Done by the Companies in the Market, (%) 231
13.3 Organic Developments. 232
13.3.1 Overview. 232
13.4 Inorganic Developments. 234
13.4.1 Overview. 234
14. Company Profiles 235
14.1 Abbott Laboratories. 235
14.1.1 Key Facts. 235
14.1.2 Business Description. 235
14.1.3 Products and Services. 236
14.1.4 Financial Overview. 237
14.1.5 SWOT Analysis. 238
14.1.6 Key Developments. 239
14.2 Bruker Corp. 240
14.2.1 Key Facts. 240
14.2.2 Business Description. 240
14.2.3 Products and Services. 241
14.2.4 Financial Overview. 241
14.2.5 SWOT Analysis. 243
14.2.6 Key Developments. 243
14.3 Cardinal Health Inc. 244
14.3.1 Key Facts. 244
14.3.2 Business Description. 244
14.3.3 Products and Services. 245
14.3.4 Financial Overview. 245
14.3.5 SWOT Analysis. 247
14.3.6 Key Developments. 247
14.4 F. Hoffmann-La Roche Ltd. 248
14.4.1 Key Facts. 248
14.4.2 Business Description. 248
14.4.3 Products and Services. 249
14.4.4 Financial Overview. 250
14.4.5 SWOT Analysis. 251
14.4.6 Key Developments. 252
14.5 Trinity Biotech Plc. 253
14.5.1 Key Facts. 253
14.5.2 Business Description. 253
14.5.3 Products and Services. 254
14.5.4 Financial Overview. 254
14.5.5 SWOT Analysis. 256
14.5.6 Key Developments. 256
14.6 Danaher Corp. 257
14.6.1 Key Facts. 257
14.6.2 Business Description. 257
14.6.3 Products and Services. 258
14.6.4 Financial Overview. 258
14.6.5 SWOT Analysis. 260
14.6.6 Key Developments. 260
14.7 Bio-Rad Laboratories Inc. 261
14.7.1 Key Facts. 261
14.7.2 Business Description. 261
14.7.3 Products and Services. 262
14.7.4 Financial Overview. 262
14.7.5 SWOT Analysis. 264
14.7.6 Key Developments. 264
14.8 AccuBioTech Co Ltd. 266
14.8.1 Key Facts. 266
14.8.2 Business Description. 266
14.8.3 Products and Services. 266
14.8.4 Financial Overview. 267
14.8.5 SWOT Analysis. 267
14.8.6 Key Developments. 268
14.9 ACON Laboratories Inc. 269
14.9.1 Key Facts. 269
14.9.2 Business Description. 269
14.9.3 Products and Services. 269
14.9.4 Financial Overview. 270
14.9.5 SWOT Analysis. 271
14.9.6 Key Developments. 271
14.10 DiaSorin SpA. 272
14.10.1 Key Facts. 272
14.10.2 Business Description. 272
14.10.3 Products and Services. 273
14.10.4 Financial Overview. 274
14.10.5 SWOT Analysis. 275
14.10.6 Key Developments. 275
15. Appendix 276
15.1 About Us. 276
15.2 Glossary of Terms. 278
List of Tables
Table 1. Infectious Disease Diagnostics Market Segmentation. 40
Table 2. Infectious Diseases and Fundings. 51
Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 63
Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 64
Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 73
Table 6. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 83
Table 7. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 85
Table 10. North America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 85
Table 11. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 13. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 87
Table 14. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 88
Table 15. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 91
Table 18. US Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 19. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 21. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 93
Table 22. Canada Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 95
Table 23. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 97
Table 26. Canada Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 97
Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 29. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 99
Table 30. Mexico Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 101
Table 31. Mexico Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 103
Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 104
Table 37. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 104
Table 38. Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 106
Table 39. Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 108
Table 42. Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 108
Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 45. Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 110
Table 46. UK Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 111
Table 47. UK Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 114
Table 50. UK Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 114
Table 51. UK Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 53. UK Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 116
Table 54. Germany Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 118
Table 55. Germany Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 120
Table 58. Germany Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 120
Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 61. Germany Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 122
Table 62. France Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 123
Table 63. France Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 126
Table 66. France Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 126
Table 67. France Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 69. France Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 128
Table 70. Italy Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 129
Table 71. Italy Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 132
Table 74. Italy Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 133
Table 77. Italy Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 133
Table 78. Spain Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 134
Table 79. Spain Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 137
Table 82. Spain Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 138
Table 85. Spain Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 138
Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 140
Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 142
Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 142
Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 144
Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 146
Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 148
Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 148
Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 150
Table 102. China Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 153
Table 103. China Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 153
Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 106. China Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 107. China Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 156
Table 109. China Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 156
Table 110. Japan Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 157
Table 111. Japan Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 160
Table 114. Japan Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 161
Table 117. Japan Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 161
Table 118. India Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 162
Table 119. India Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 165
Table 122. India Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 123. India Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 166
Table 125. India Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 166
Table 126. South Korea Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 167
Table 127. South Korea Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 170
Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 171
Table 133. South Korea Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 171
Table 134. Australia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 172
Table 135. Australia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 175
Table 138. Australia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 176
Table 141. Australia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 176
Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 177
Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 180
Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 180
Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 182
Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 184
Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 186
Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 186
Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 188
Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 189
Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 192
Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 193
Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 193
Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 194
Table 167. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 197
Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 198
Table 173. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 198
Table 174. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 199
Table 175. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 202
Table 178. UAE Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 203
Table 181. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 203
Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 204
Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 207
Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 207
Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 209
Table 190. South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 211
Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 213
Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 213
Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 197. South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 215
Table 198. Brazil Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 216
Table 199. Brazil Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 219
Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 220
Table 205. Brazil Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 220
Table 206. Argentina Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 221
Table 207. Argentina Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 224
Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 225
Table 213. Argentina Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 225
Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 226
Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 228
Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 228
Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 230
Table 222. Organic Developments Done By Companies. 232
Table 223. Inorganic Developments Done By Companies. 234
Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278
List of Figures
Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41
Figure 2. Global - PEST Analysis. 47
Figure 3. Infectious Disease Diagnostics Market - Key Industry Dynamics. 48
Figure 4. Impact Analysis of Drivers and Restraints. 53
Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54
Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 – 2030. 55
Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57
Figure 9. Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58
Figure 10. Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59
Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
Figure 12. Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61
Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62
Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64
Figure 15. Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66
Figure 16. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67
Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69
Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70
Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
Figure 21. Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72
Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74
Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76
Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77
Figure 26. Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78
Figure 27. Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80
Figure 28. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81
Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2022) (US$ Million) 82
Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87
Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 105
Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110
Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 145
Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151
Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 183
Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188
Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 210
Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215
Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231
The List of Companies - Infectious Disease Diagnostics Market
- Abbott Laboratories
- Bruker Corp
- Cardinal Health
- F. Hoffmann-La Roche Ltd
- Trinity Biotech Plc
- Danaher Corp
- Bio-Rad Laboratories Inc
- AccuBioTech Co Ltd
- ACON Laboratories
- DiaSorin SpA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For